NCT00003537View on ClinicalTrials.gov

Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 1995

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Adult Brain Tumor
Interventions
DRUG

Antineoplaston therapy (Atengenal + Astugenal)

Adults with an anaplastic astrocytoma will receive Antineoplaston therapy (Atengenal + Astugenal).

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER